Key result
Endovascular treatment did not lower stroke recurrence vs conservative management in VBD.
Why the study?
Vertebrobasilar dolichoectasia carries a substantial risk of ischemic and hemorrhagic stroke, but whether endovascular treatment or surgery lowers this risk relative to conservative management remained unclear because prior pooled analyses largely reported natural-history cohorts alone.
Does endovascular or surgical treatment reduce post-treatment stroke recurrence and mortality compared with conservative management in patients with vertebrobasilar dolichoectasia?
Meta-Analysis (n=628)
Does endovascular or surgical treatment reduce post-treatment stroke recurrence and mortality compared with conservative management in patients with vertebrobasilar dolichoectasia?
Neither classical nor Bayesian meta-analysis of observational studies showed convincing evidence that endovascular or surgical intervention lowers stroke recurrence or mortality compared with conservative management in vertebrobasilar dolichoectasia.
Answers are grounded in this paper and cite their sources.
Conservative management remains reasonable for vertebrobasilar dolichoectasia; leaves open whether endovascular treatment benefits selected patients in randomized trials.
Introduction: Vertebrobasilar dolichoectasia (VBD) carries a substantial risk of ischemic and hemorrhagic stroke, yet whether endovascular treatment (EVT) or surgery lowers this risk relative to conservative management remains unclear, since prior pooled analyses have largely reported natural-history cohorts alone. We performed a classical and Bayesian meta-analysis directly comparing post-treatment stroke recurrence and mortality across EVT, surgical, and conservative management strategies. Methods: We pooled treatment-arm-level data from published observational studies of VBD reporting patient counts, follow-up person-years, and stroke or mortality events (1989-2024). Arms were categorized as EVT, surgical, or conservative. Random-effects meta-analysis of incidence rates (per 100 person-years) used DerSimonian-Laird log-rate pooling; heterogeneity was quantified with I². A hierarchical Bayesian Poisson-Gamma model was fit per treatment group to obtain posterior rate estimates and the posterior probability that EVT incidence exceeded conservative incidence. Stroke-recurrence analysis included 20 arms from 16 studies (628 patients, 2,880 person-years); mortality analysis included 15 arms from 11 studies (451 patients). Results: Pooled stroke recurrence was 13.4 per 100 person-years for EVT (95% CI 7.3-24.7), 8.0 for conservative management (2.8-23.1), and 8.2 for surgical treatment (2.4-28.5); heterogeneity was substantial (I² 80-92%). The Bayesian model gave comparable estimates (EVT 17.1 [8.7-33.2]; conservative 12.6 [3.4-45.3]), with a posterior probability of only 0.65 that EVT recurrence exceeded conservative recurrence, weak and inconclusive evidence of a difference. Mortality was more homogeneous (I² 0%): 6.4 per 100 person-years for EVT (4.4-9.4) versus 5.1 for conservative management (3.9-6.7); posterior probability that EVT mortality exceeded conservative mortality was 0.57, which is essentially equivalent. Conclusion: Across pooled observational data, neither classical nor Bayesian modeling found convincing evidence that endovascular or surgical treatment lowers post-treatment stroke recurrence or mortality compared with conservative management of VBD; point estimates numerically favored conservative management for stroke recurrence, but wide, overlapping intervals reflect small samples and likely confounding by indication, since more severe cases are preferentially treated. Several mortality arms contributed zero observed events over limited person-time, which can narrow apparent between-study heterogeneity without reflecting genuine precision. Prospective, risk-adjusted comparative studies are needed before treatment can be shown to alter this disease's natural history.
No takes yet. Share an insight, caveat, or question.
Bakhsh et al. (2026) conducted a meta-analysis in Vertebrobasilar dissection/dolichoectasia (VBD) (n=628). Endovascular treatment (EVT) or surgical treatment vs. Conservative management was evaluated on Post-treatment stroke recurrence (per 100 person-years). Endovascular treatment did not lower stroke recurrence vs conservative management in VBD.
Synapse has enriched 10 related papers. Consider them for comparative context: